Two new trials saw no impact of thrombolytics in reducing disability at 90 days, but some positive signals offer hope.

An app-based program failed to boost function for most at 3 months, but positive signs were seen in women and after CABG.

The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.

The agency says the strategy would help millions quit and prevent 4.3 million tobacco-related deaths by the end of the ...

Iulia Iatan talks to C. Michael Gibson about how a low-carbohydrate, high-protein diet can increase plasma lipid levels and cardiovascular risk.